Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 38.58M
June 30, 2026 9.994M
March 31, 2026 -0.025M
December 31, 2025 0.669M
September 30, 2025 -0.008M
June 30, 2025 -0.067M
March 31, 2025 0.00
December 31, 2024 0.129M
September 30, 2024 1.638M
June 30, 2024 0.048M
March 31, 2024 57.51M
December 31, 2023 -0.025M
Date Value
September 30, 2023 -0.171M
June 30, 2023 6.125M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.006M
June 30, 2022 0.001M
March 31, 2022 0.176M
December 31, 2021 154.90M
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020 0.001M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 57.26M
Cue Biopharma, Inc. 50.63M
Yarrow Bioscience, Inc. 265.03M
Faeth Therapeutics, Inc. 0.104M
Indaptus Therapeutics, Inc. 20.30M